Specifically, EA can modulate the release of pro-inflammatory cytokines such as IL-6, TNF-α, and IL-1β, which are key mediators of the inflammatory response in musculoskeletal disorders. This evidence concerns the gene IL1B and musculoskeletal system disorder.